SCHEMBL29676771

SCHEMBL29676771

Cc1cc(-c2cc(Cl)ncn2)ccc1CNC(=O)N1CC(OC(C)C)C1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 11/20 0.59
▸ AAK1 Q2M2I8 4/20 0.59
▸ JAK2 O60674 1/20 0.59
▸ CYP3A4 P08684 1/20 0.59
▸ HRH2 P25021 1/20 0.59
▸ CDK7 P50613 1/20 0.59
▸ CD69 Q07108 1/20 0.59
▸ MAP3K19 Q56UN5 1/20 0.59
▸ CDKL2 Q92772 1/20 0.59
▸ RIOK1 Q9BRS2 1/20 0.59
▸ RIOK2 Q9BVS4 1/20 0.59
▸ BMP2K Q9NSY1 1/20 0.59
▸ GHSR Q92847 1/20 0.37
▸ EPHX2 P34913 2/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ CYP2J2 P51589 1/20 0.35
▸ P2RX7 Q99572 1/20 0.35
▸ P2RY12 Q9H244 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16793760 1.00 BTK (0.59) BTKAAK1JAK2CYP3A4HRH2
SCHEMBL20461055 0.87 BTK (0.61) BTKAAK1JAK2CYP3A4HRH2
SCHEMBL29676750 0.85 BTK (0.69) BTKAAK1JAK2CYP3A4HRH2
SCHEMBL16794224 0.85 BTK (0.69) BTKAAK1JAK2CYP3A4HRH2
SCHEMBL25584965 0.82 BTK (0.59) BTKAAK1JAK2CYP3A4HRH2
SCHEMBL29986746 0.81 BTK (0.69) BTKAAK1JAK2CYP3A4HRH2
SCHEMBL28881293 0.81 BTK (0.69) BTKAAK1JAK2CYP3A4HRH2
SCHEMBL18170395 0.80 BTK (0.52) BTKAAK1JAK2CYP3A4HRH2
SCHEMBL16794261 0.79 BTK (0.53) BTKAAK1JAK2CYP3A4HRH2
SCHEMBL18183954 0.78 BTK (0.52) BTKAAK1JAK2CYP3A4HRH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109096274-B Biaryl compounds useful in the treatment of human oncological, neurological and immunological diseases 比奥根MA公司 2022-07-01 — — CN disclosed
Send feedback